By Kemo Cham
[First published on www.politicosl.com] An Ebola vaccine candidate trialed
in Guinea, Liberia and Sierra Leone has been found to provide 100 percent
protection, raising hopes for a potential prevention of the deadly hemorrhagic
fever disease, the World Health Organisation (WHO) announced Friday.
The breakthrough comes nearly
a year after the end of the world’s deadliest Ebola outbreak that wreaked havoc in West Africa between
2014 and 2016. Over 11,300 people died, out of more than 28,000
cases globally, according to figures from
WHO.
Sierra Leone, Liberia and
Guinea, where it all started, bore the brunt of the cases and fatalities.